Teleflex plans to spin off its Urology ... supraglottic airways, and endotracheal tubes, as well as our pain management portfolio, consisting of epidurals, catheters and disposable pain pumps ...

Various factors can affect the extent of the effect on the respiratory system, such as the type of anesthetic given, spontaneous or controlled ventilation, and the airway (endotracheal tube or ...

ICU Medical's Smiths Medical today announced that it warned of a potential issue with certain sizes of its endotracheal tubes.

"Smiths Medical issues urgent medical device correction for certain Portex intubation tubes due to manufacturer defect, posing serious risk of inadequate ventil ...

Teleflex to create a new, independent publicly traded company ("NewCo”) consisting of Teleflex's Urology, Acute Care, and OEM businesses. Teleflex RemainCo ("RemainCo”) will consist of Teleflex's ...

Teleflex is separating into two publicly traded companies to optimize growth and shareholder value. The acquisition of Biotronik's Vascular Intervention expands Teleflex's presence in coronary and ...

Teleflex announced a major strategic pivot, planning to separate into two independent publicly traded companies to maximize shareholder value. The separation, expected to complete by mid-2026 ...

Shares of TFX opened at $134.38 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex has a one year low of $128.55 and a one year ...

Investing.com -- Moody’s Ratings has revised the outlook for Teleflex (NYSE:TFX) Incorporated to negative from stable, while affirming the company’s Ba1 Corporate Family Rating (CFR), Ba1-PD ...

TFX opened at $132.58 on Friday. Teleflex has a fifty-two week low of $130.60 and a fifty-two week high of $249.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a ...